Overall, based on the existing, available literature, we suggest that targeting the Nrf2/Keap1/NF-κB signaling pathways via bioactive compounds holds great promise for improving reproductive health and can be considered a potential therapeutic target to mitigate endometritis in livestock animals and humans. The gene discussed is NFE2L2; the disease is endometritis.